Patents by Inventor Jason D. ROH

Jason D. ROH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR PREVENTING AND TREATING HEART DISEASE
    Publication number: 20240158514
    Abstract: The disclosure relates to novel uses and methods for preventing and/or treating heart disease, which employ a therapeutically effective amount of an ActRII receptor antagonist, e.g., an ActRII receptor binding molecule, e.g., an ActRII receptor antibody, such as the bimagrumab antibody.
    Type: Application
    Filed: October 18, 2023
    Publication date: May 16, 2024
    Inventors: Anthony ROSENZWEIG, Jason D. ROH, David J. GLASS
  • Method of treating structural and/or functional cardiac abnormalities by administering an anti-ActRII receptor antibody
    Patent number: 11834508
    Abstract: The disclosure relates to novel uses and methods for preventing and/or treating heart disease, which employ a therapeutically effective amount of an ActRII receptor antagonist, e.g., an ActRII receptor binding molecule, e.g., an ActRII receptor antibody, such as the bimagrumab antibody.
    Type: Grant
    Filed: March 16, 2021
    Date of Patent: December 5, 2023
    Assignees: Novartis AG, Beth Israel Deaconess Medical Center, Inc.
    Inventors: Anthony Rosenzweig, Jason D. Roh, David J. Glass
  • METHODS FOR PREVENTING AND TREATING HEART DISEASE
    Publication number: 20210309749
    Abstract: The disclosure relates to novel uses and methods for preventing and/or treating heart disease, which employ a therapeutically effective amount of an ActRII receptor antagonist, e.g., an ActRII receptor binding molecule, e.g., an ActRII receptor antibody, such as the bimagrumab antibody.
    Type: Application
    Filed: March 16, 2021
    Publication date: October 7, 2021
    Inventors: Anthony ROSENZWEIG, Jason D. ROH, David J. GLASS
  • Methods for treating and/or reducing the likelihood of heart failure by administering anti-activin receptor type II (anti-ActRII) antibody
    Patent number: 10982000
    Abstract: The disclosure relates to novel uses and methods for preventing and/or treating heart disease, which employ a therapeutically effective amount of an ActRII receptor antagonist, e.g., an ActRII receptor binding molecule, e.g., an ActRII receptor antibody, such as the bimagrumab antibody.
    Type: Grant
    Filed: March 20, 2018
    Date of Patent: April 20, 2021
    Assignees: Novartis AG, Beth Israel Deaconess Medical Center, Inc.
    Inventors: Anthony Rosenzweig, Jason D. Roh, David J. Glass
  • METHODS FOR PREVENTING AND TREATING HEART DISEASE
    Publication number: 20200031940
    Abstract: The disclosure relates to novel uses and methods for preventing and/or treating heart disease, which employ a therapeutically effective amount of an ActRII receptor antagonist, e.g., an ActRII receptor binding molecule, e.g., an ActRII receptor antibody, such as the bimagrumab antibody.
    Type: Application
    Filed: March 20, 2018
    Publication date: January 30, 2020
    Inventors: Anthony ROSENZWEIG, Jason D. ROH, David J. GLASS